Literature DB >> 2122088

Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations.

B Rouse1, L Lockhart, R Matalon, C Azen, R Koch, W Hanley, H Levy, F dela Cruz, E Friedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2122088     DOI： 10.1007/bf01799376

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  2 in total

1.  MATERNAL PHENYLKETONURIA. A CAUSE OF MENTAL RETARDATION IN CHILDREN WITHOUT THE METABOLIC DEFECT.

Authors:  C C MABRY; J C DENNISTON; T L NELSON; C D SON
Journal:  N Engl J Med       Date:  1963-12-26       Impact factor: 91.245

2.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245
  2 in total
  8 in total

1.  Maternal PKU collaborative study: the effect of nutrient intake on pregnancy outcome.

Authors:  R Matalon; K Michals; C Azen; E G Friedman; R Koch; E Wenz; H Levy; F Rohr; B Rouse; L Castiglioni
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Maternal PKU Collaborative Study: pregnancy outcome and postnatal head growth.

Authors:  R Matalon; K Michals; C Azen; E Friedman; R Koch; B Rouse; W B Hanley; F de la Cruz
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.

Authors:  S Kleiman; L Vanagaite; J Bernstein; G Schwartz; N Brand; A Elitzur; S L Woo; Y Shiloh
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

4.  The North American Maternal Phenylketonuria Collaborative Study, developmental assessment of the offspring: preliminary report.

Authors:  W B Hanley; R Koch; H L Levy; R Matalon; B Rouse; C Azen; F de la Cruz
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

5.  Nutrition and reproductive outcome in maternal phenylketonuria.

Authors:  K Michals; P B Acosta; V Austin; L Castiglioni; F Rohr; E Wenz; C Azen
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  Benefits of normalizing plasma phenylalanine: impact on behaviour and health. A case report.

Authors:  K Williams
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

7.  High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU.

Authors:  Sankar Surendran; Gerald A Campbell; Stephen K Tyring; Kimberlee Matalon; J David McDonald; Reuben Matalon
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

8.  Cell encapsulation as a potential nondietary therapy for maternal phenylketonuria.

Authors:  Donna A Santillan; Mark K Santillan; Stephen K Hunter
Journal:  Am J Obstet Gynecol       Date:  2009-07-24       Impact factor: 8.661
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.